BG Medicine's heart failure Dx wins higher CMS coverage; Blood test to screen for presymptomatic Alzheimer's advances;

> BG Medicine's ($BGMD) stock price doubled Dec. 10 after the Centers for Medicare and Medicaid Services nearly doubled the reimbursement price for the company's test that allows for early detection of chronic heart failure. Story

> King's College London researchers said they've made major progress on a blood test that could screen for Alzheimer's before clinical symptoms appear. Story

> Navidea Biopharmaceuticals ($NAVB) won special designation from the FDA to expedite a supplemental new drug application to use Lymphoseek injection to help map lymph nodes in patients with head and neck cancer. Item

> Bermuda's Health Ministry is considering rules that would require precertification before patients can undergo medical diagnostic procedures. Story

> Home diagnostic testing devices could help monitor epilepsy drug levels, according to two new studies presented at the American Epilepsy Society's 67th Annual Meeting in Washington, D.C. Item

> Viracor-IBT, a specialty diagnostics lab focused on immunology, infectious disease and allergy testing, has snatched up the National Institute of Transplantation's Los Angeles-based serology and HLA laboratory operations. Story

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

A COVID-19 antibody diagnostic developed through a joint venture between Mount Sinai Health System and RenalytixAI has been authorized by the FDA.

Researchers at Northwestern University have trained an AI algorithm to automatically detect the signs of COVID-19 on a basic X-ray of the lungs.

Hand-held ultrasound developer Butterfly Network is going public through a $1.5 billion acquisition deal backed by Glenview Capital.